Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucormycosis in leukemia

S W Rosenberg, J B Lepley

    Oral Surgery, Oral Medicine, and Oral Pathology
    |July 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Rhinocerebral mucormycosis is a deadly fungal infection, often fatal in leukemia patients. Early diagnosis and treatment are crucial for managing this aggressive illness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Removable partial overdentures for the irradiated patient.

    Dental clinics of North America·1990
    Same author

    Oral care of chemotherapy patients.

    Dental clinics of North America·1990
    Same author

    Oral complications of cancer therapies. Chronic dental complications.

    NCI monographs : a publication of the National Cancer Institute·1990
    Same author

    Altered dental root development in long-term survivors of pediatric acute lymphoblastic leukemia. A review of 17 cases.

    Cancer·1987
    Same author

    Oral complications of cancer chemotherapy--a review of 398 patients.

    Journal of oral medicine·1986
    Same author

    Behavior management of the pediatric oncology patient. A case report.

    The New York journal of dentistry·1986

    Area of Science:

    • Infectious Diseases
    • Mycology
    • Hematology

    Background:

    • Rhinocerebral mucormycosis is a severe, rapidly progressing fungal infection.
    • It primarily affects individuals with uncontrolled diabetes but also occurs in other immunosuppressed populations.
    • Leukemia patients with this infection have historically faced a uniformly fatal outcome.

    Observation:

    • Presents a case of fatal rhinocerebral mucormycosis in a leukemic patient.
    • Highlights the diagnostic and therapeutic challenges in managing this condition.
    • Reviews 233 previously reported cases from the literature.

    Findings:

    • Discusses the pathogenesis, diagnosis, and management strategies for rhinocerebral mucormycosis.
    • Emphasizes the aggressive nature and high mortality rate, particularly in leukemic hosts.

    Related Experiment Videos

  • Underscores the need for prompt medical and potential surgical intervention.

    • Implications:

    • Informs clinicians about the critical need for early recognition and aggressive management of rhinocerebral mucormycosis.
    • Contributes to understanding the disease's progression and outcomes in immunosuppressed patients.
    • Provides a basis for further research into effective therapeutic approaches for this life-threatening infection.